Advertisement|Remove ads.

TruBridge Inc. (TBRG), a leading provider of healthcare technology solutions for rural and community hospitals, announced on Monday that it has postponed its fourth-quarter (Q4) and year-end 2025 earnings release and conference call.
TruBridge said that it requires additional time for the completion of its year-end audit procedures, and was therefore delaying its results previously scheduled for March 16, 2026.
The company will issue a separate announcement confirming the date of the release of fourth quarter and year-end 2025 financial results, it said.
Shares of the company declined more than 5% after the announcement.
TruBridge said that while conducting final procedures with the preparation of its financial statements for the fiscal year ended Dec. 31, 2025, errors were identified in the consolidated financial statements for the year ended Dec. 31, 2024 as well as out-of-period errors in the condensed financial statements for the quarters ended March 31, June 30, and Sept. 30, 2025.
The majority of these errors relate to accounting for revenue, software development costs, and share-based payments.
TBRG said that the above-mentioned errors did not result in a material misstatement of its previously issued financial statements, and the errors are non-cash in nature, and do not impact company’s operations or liquidity.
TruBridge expects to file the 2025 Form 10-K within the 15-day extension period granted by the U.S. Securities and Exchange Commission (SEC), as well as issue its Q4 and year-end 2025 financial results and hold its rescheduled earnings call by March 31, 2026.
Retail sentiment around TBRG stock trended in ‘neutral territory’ amid ‘high’ message volume.
Shares in the company have fallen 25% so far in 2026.